740. Deputy Michael Collins asked the Minister for Health if guidance will be issued (details supplied) to pharmacies to allow patients who depend on essential prescribed medicines, including pregabalin, to obtain a limited emergency supply for use during prolonged power outages, evacuations or other disruptions. [71551/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Pharmacy Services.
165 questions match, newest first.
751. Deputy David Cullinane asked the Minister for Health the level of fees collected by pharmacies for services provided under the common conditions scheme, in tabular form; the number of consultations and other measurable outputs this relates to; the extent of data collected on services operated under the common conditions scheme; if this data is not collected, the reason; and whether she intends to collect it. [68…
445. Deputy Colm Burke asked the Minister for Health whether consideration will be given to issuing clear and nationally consistent guidance to pharmacies and non-pharmacy retailers regarding the sale of paracetamol and other commonly available medicines to children and adolescents. [67824/26]
446. Deputy Colm Burke asked the Minister for Health whether her Department will examine the introduction of a statutory minimum age for the purchase of over the counter paracetamol products, having regard to safeguarding concerns relating to children and adolescents. [67823/26]
447. Deputy Colm Burke asked the Minister for Health to clarify the current legal position regarding the sale of over the counter paracetamol products to persons under 18 years-of-age; and whether any statutory minimum age currently applies in pharmacies or non-pharmacy retail outlets. [67822/26]
171. Deputy Cathal Crowe asked the Minister for Health for an update on the implementation of the Programme for Government commitments regarding pharmacists and pharmacy services. [67415/26]
611. Deputy Roderic O'Gorman asked the Minister for Health the policy with respect to a prescription for a ‘months’ worth of drugs; whether this represents a generic 28 days work of drugs, or can it represent 29, 30 or 31 days of the drug depending on the month; and if it can only represent 28 days, is it acceptable that this will require a second dispensing during that month. [66799/26]
500. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 461 of 2 July 2026, if a patient who was receiving blister packs free-of-charge prior to the Community Pharmacy Agreement 2025 changes pharmacists, if this patient is still entitled to receive this service free-of-charge (details supplied); and if she will make a statement on the matter. [54384/26]
511. Deputy Pádraig Rice asked the Minister for Health the number of pharmacies participating in the free contraception scheme, by county, in tabular form. [54414/26]
512. Deputy Pádraig Rice asked the Minister for Health the number of pharmacies in the State, by county, in tabular form. [54415/26]
370. Deputy Pádraig O'Sullivan asked the Minister for Health the number of community pharmacies participating in the common conditions service; the findings to date of the data collection exercise involving the 150 data champion pharmacies which commenced in July 2026; and if she will make a statement on the matter. [53755/26]
372. Deputy Pádraig O'Sullivan asked the Minister for Health the number of community pharmacy contractors that have provided notice of participation in Phase 1 of the BowelScreen community pharmacy intervention; the projected cost of the per patient service fee under Phase 2; and if she will make a statement on the matter. [53757/26]
373. Deputy Pádraig O'Sullivan asked the Minister for Health the number of community pharmacy contractors in receipt of the emergency medicine administration preparedness allowance introduced under the Community Pharmacy Agreement 2025; the number of recorded administrations of naloxone in community settings in 2025; and if she will make a statement on the matter. [53758/26]
210. Deputy Seán Ó Fearghaíl asked the Minister for Health the key measures taken to improve pharmacy services since January 2025; her priorities for same for the rest of 2026; and if she will make a statement on the matter. [51932/26]
841. Deputy Darren O'Rourke asked the Minister for Health the position regarding the charging by pharmacists for blister packs, for those who can neither afford the new charges or take the risk of incorrect dosage; and if she will make a statement on the matter. [44944/26]
960. Deputy Naoise Ó Muirí asked the Minister for Health if she will examine a PCRS case (details supplied); her views on whether it is fair that that the pharmacy is liable for this deduction when they are unable to view the visibility of stocks held by PCRS; and if she will make a statement on the matter. [45562/26]
2140. Deputy Erin McGreehan asked the Minister for Health for an update on allowing pharmacies to consult with patients and prescribe for the free contraception scheme; and if she will make a statement on the matter. [42934/26]
1331. Deputy Sorca Clarke asked the Minister for Health when she expects to see an on-site pharmacy at a location (details supplied); and if she will make a statement on the matter. [39302/26]
1355. Deputy Paul Donnelly asked the Minister for Health further to Parliamentary question No. 544 of 14 May 2026, if people can access their prescription such as a locker type dispenser that has been placed on the outside of a pharmacy after closure. [39476/26]
1046. Deputy Ken O'Flynn asked the Minister for Health the total number of rejected or unpaid pharmacy claims recorded under the General Medical Services Scheme in each year from 2020 to 2026, in tabular form [36795/26]
1047. Deputy Ken O'Flynn asked the Minister for Health the most common categories of rejected pharmacy claims under the General Medical Services Scheme in each year since 2020. [36796/26]
1048. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the number of rejected claims relating specifically to respiratory medications including salbutamol, ipratropium, steroid inhalers and nebuliser products. [36797/26]
1049. Deputy Ken O'Flynn asked the Minister for Health whether any audit, review, or risk assessment has been conducted examining the patient safety implications of rejected pharmacy claims under the PCRS system in the past five years. [36798/26]
1050. Deputy Ken O'Flynn asked the Minister for Health whether pharmacies are financially disadvantaged where claims are repeatedly rejected due to software or administrative validation issues. [36799/26]
1073. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been carried out into the financial impact of rejected pharmacy claims on community pharmacies. [36914/26]